← 返回

ITPKB 是限制抗肿瘤免疫的 NK 细胞脱敏/教育的保守调控因子

英文原题:ITPKB is a conserved regulator of natural killer cell desensitization/education that constrains antitumor immunity.

查看英文原题

ITPKB is a conserved regulator of natural killer cell desensitization/education that constrains antitumor immunity.

PubMed 2026/07/17(内容时间) bioRxiv

分数与星级只用于站内排序 —— 不代表疗效、安全性或个人适用性。

中文摘要

持续刺激诱导的Natural Killer (NK)细胞脱敏限制了持久的抗肿瘤免疫,然而调控这一功能障碍状态的分子机制仍不明确。为鉴定NK细胞脱敏的保守调控因子,我们在多种持续性激活和功能障碍的小鼠模型中进行了比较转录组分析。该方法定义了脱敏的共享转录程序,并鉴定出Itpkb在多个不同情境中上调。在多种脱敏条件下,ITPKB的遗传学和药理学抑制增强了小鼠和人类NK细胞的脱颗粒、细胞因子产生和细胞毒性。机制上,ITPKB通过IP 3 /IP 4 轴调控持续性激活下游的信号传导,限制脱敏NK细胞中的钙动员和NFAT依赖性转录反应。此外,抑制或缺失ITPKB增强了体内NK细胞介导的肿瘤控制,并提高了过继转移CAR-NK细胞的疗效,凸显了靶向该通路的转化潜力。总之,这些发现将ITPKB鉴定为NK细胞脱敏的细胞内在调控因子,并支持靶向IP 3 /IP 4 信号轴以增强NK细胞介导的抗肿瘤免疫。

展开英文摘要原文

Natural Killer (NK) cell desensitization induced by persistent stimulation limits durable antitumor immunity, yet the molecular mechanisms governing this dysfunctional state remain poorly defined. To identify conserved regulators of NK cell desensitization, we performed comparative transcriptomic analyses across multiple murine models of persistent activation and dysfunction.

This approach defined a shared transcriptional program of desensitization and identified Itpkb to be upregulated across multiple distinct contexts. Genetic and pharmacological inhibition of ITPKB enhanced degranulation, cytokine production, and cytotoxicity in both murine and human NK cells under multiple desensitization settings.

Mechanistically, ITPKB regulated signaling downstream of persistent activation through the IP 3 /IP 4 axis, limiting calcium mobilization and NFAT-dependent transcriptional responses in desensitized NK cells.

Furthermore, inhibition or deletion of ITPKB enhanced NK-cell mediated tumor control in vivo and improved the efficacy of adoptively transferred CAR-NK cells, underscoring the translational potential of targeting this pathway.

Together, these findings identify ITPKB as a cell-intrinsic regulator of NK cell desensitization and support targeting the IP 3 /IP 4 signaling axis to enhance NK cell-mediated antitumor immunity.

论文信息

作者
Jo Y、Karampatzakis A、Lee SW、Peng A、Ghouri Z、Moya M、Andrews E、Sudholz H
单位
Division of Immunology and Molecular Medicine, Department of Molecular and Cell Biology, University of California, Berkeley, Berkeley, CA, USA.United States
文献类型
预印本
期刊
bioRxiv : the preprint server for biology2026 Jul 17
原文标识
PubMed 42523281 · DOI 10.64898/2026.07.12.738073